Atlas Trials

Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study

Clinical trial NCT01865162 · COMPLETED

Trial details

NCT number
NCT01865162
Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2013-01-01
Primary completion
2021-01-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.